Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)

This study has been terminated.
(Difficulty finding subjects who met the inclusion/exclusion criteria.)
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00906035
First received: May 20, 2009
Last updated: January 31, 2013
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)